![Kymriah vs. Yescarta [UPDATED]](https://nucleusbiologics.com/wp-content/uploads/2019/05/kymriah-vs-yescarta-feat.jpg)
by Dr. Alyssa Master | Aug 20, 2019
Kymriah® and Yescarta® are currently the only two FDA-approved CAR-T cell therapy products available on the market in the United States. Do you have trouble distinguishing between them? We created a simple chart to showcase some of the similarities and differences...
by Dr. Alyssa Master | Aug 5, 2019
Nucleus Biologics™ now has the leading xeno-free, recombinant, extracellular matrix SAN DIEGO – August 6, 2019 – Nucleus Biologics™, a leader in precision cell culture, is pleased to announce the acquisition of Primorigen Biosciences, Inc. The addition...
by Ashley Fallon | Jul 16, 2019
Islet cell transplantation is an experimental treatment for Type 1 diabetes. Islet cells are responsible for producing and secreting insulin. Without proper islet cell function, a patient becomes dependent on insulin injections. To alleviate this dependency, islet...
by Ashley Fallon | Jul 10, 2019
The cell therapy field has experienced rapid growth over the last few years! As our knowledge increases, so do the number of cell and gene therapy conferences. There are so many to choose from in North America, but we can’t ignore the rest of the world! Check...
![Top 10 Cell Therapy Conferences for 2019 [UPDATED]](https://nucleusbiologics.com/wp-content/uploads/2018/10/Top-10-Conferences_featured.jpg)
by Dr. Alyssa Master | Jun 1, 2019
Cell therapy is booming and there is something new to learn every day! It feels like every week there is a new conference, but one person couldn’t possibly attend them all. For those with a narrow budget, both time and money, here are the top 10 cell therapy...
